OncoGenex Pharma (OGXI) Reports In-Line Q1 EPS

OncoGenex Pharma (NASDAQ: OGXI) reported Q1 EPS of ($0.12), in-line with the analyst estimate of ($0.12). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $4.09 million.

For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Innovaro (INV) Misses Q2 EPS by 9c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance